Skip to main content

Table 3 Association between medical cannabis authorization and the risk of hospitalization or emergency department (ED) visits for acute coronary syndrome (ACS) or stroke (primary outcome) and for any cardiovascular (CV) event (secondary outcome)

From: Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study

Outcome

Statistical model

Hazard ratio (95% confidence interval)

Primary outcome (ACS or stroke)

Conditional Cox model*

1.48 (1.11–1.97)

Conditional model further adjusted for prior ACS or stroke and area of living

1.41 (1.05–1.90)

Conditional model adjusted for history of any CV event and area of living

1.44 (1.08–1.93)

Secondary outcome (any CV event)

Conditional Cox model*

1.52 (1.31–1.77)

Conditional model further adjusted for history of any CV event and for area of living (rural versus urban)

1.47 (1.26–1.72)

  1. *Accounts for the matching that was based on age, sex, income quartile and previous diagnosis of: diabetes, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), asthma, cancer, musculoskeletal disorders, neurological disorders, pain, fatigue, behavioural disorders, malnutrition, and metabolic disease